Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Kabiru Sahabi, Gayathri T. Selvarajah, Ajat Mokrish, Abdullah Rasedee & Cheah Y. Kqueen. (2022) Development and molecular characterization of doxorubicin-resistant canine mammary gland tumour cells. Journal of Applied Animal Research 50:1, pages 125-145.
Read now
Read now
Simran Kaur, Mohammad Zeeshan Najm, Mohammad Aasif Khan, Naseem Akhter, Vyas M Shingatgeri, Mudra Sikenis, Sadaf & Abdulaziz A Aloliqi. (2021) Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment. Breast Cancer: Targets and Therapy 13, pages 691-700.
Read now
Read now
Xiang Li, Qian Zou, Jing Zhang, Peng Zhang, Xiong Zhou, Satya Siva Kishan Yalamarty, Xinli Liang, Yali Liu, Qin Zheng & Jianqing Gao. (2020) Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer. International Journal of Nanomedicine 15, pages 6791-6811.
Read now
Read now
João Marcos de Azevedo Delou, Giselle Maria Vignal, Vanessa Índio-do-Brasil, Maria Theresa de Souza Accioly, Taiana Sousa Lopes da Silva, Diogo Nascimento Piranda, Marcelo Sobral-Leite, Marcelo Alex de Carvalho, Márcia Alves Marques Capella & Rosane Vianna-Jorge. (2017) Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis. Breast Cancer: Targets and Therapy 9, pages 415-428.
Read now
Read now
Émilie A. Graham, Jean-François Mallet, Majed Jambi, Hiroshi Nishioka, Kohei Homma & Chantal Matar. (2017) MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC). Cancer Biology & Therapy 18:10, pages 765-774.
Read now
Read now
Mari Masuda & Tesshi Yamada. (2017) Signaling pathway profiling using reverse-phase protein array and its clinical applications. Expert Review of Proteomics 14:7, pages 607-615.
Read now
Read now
Chongwen Xu, Xin Sun, Sida Qin, Huangzhen Wang, Zhiwei Zheng, Shaohua Xu, Gang Luo, Peng Liu, Jian Liu, Ning Du, Yunfeng Zhang, Dapeng Liu & Hong Ren. (2015) Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cells. Cell Cycle 14:11, pages 1686-1697.
Read now
Read now
Fiona Haxho, Stephanie Allison, Farah Alghamdi, Lacey Brodhagen, Victoria EL Kuta, Samar Abdulkhalek, Ronald J Neufeld & Myron R Szewczuk. (2014) Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma. Breast Cancer: Targets and Therapy 6, pages 191-203.
Read now
Read now
Articles from other publishers (24)
Prithwish Kola, Prasanth Kumar Bhusetty Nagesh, Pritam Kumar Roy, K. Deepak, Rui Luis Reis, Subhas C. Kundu & Mahitosh Mandal. (2023) Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances. WIREs Nanomedicine and Nanobiotechnology 15:4.
Crossref
Crossref
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies & Rajesh Singh. (2023) Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer. Cancers 15:4, pages 1320.
Crossref
Crossref
Yaxin Wang, Zhi Tong, Yajie Zhou, Xueru Guo, Mingjiang Zhang, Shanshan Zhao & Taotao Zhuang. (2023) Chiral inorganic nanostructures for theranostics. JUSTC 53:3, pages 0303.
Crossref
Crossref
Mengyu Yao, Xueqin Hao, Hongwei Shao, Donghui Wang, Baoe Li, Shun Xing, Xuefeng Zhao, Chi Zhang, Xuanyong Liu, Yu Zhang & Feng Peng. (2022) Metallic Nanoparticle-Doped Oxide Semiconductor Film for Bone Tumor Suppression and Bone Regeneration. ACS Applied Materials & Interfaces 14:42, pages 47369-47384.
Crossref
Crossref
Carlos Garcia-Padilla, Estefanía Lozano-Velasco, María del Mar Muñoz-Gallardo, Juan Manuel Castillo-Casas, Sheila Caño-Carrillo, Francisco José Martínez-Amaro, Virginio García-López, Amelia Aránega, Diego Franco, Virginio García-Martínez & Carmen López-Sánchez. (2022) LncRNA H19 Impairs Chemo and Radiotherapy in Tumorigenesis. International Journal of Molecular Sciences 23:15, pages 8309.
Crossref
Crossref
Shriya Joshi, Chakravarthy Garlapati, Shristi Bhattarai, Yixin Su, Leslimar Rios-Colon, Gagan Deep, Mylin A. Torres & Ritu Aneja. (2022) Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer. International Journal of Molecular Sciences 23:10, pages 5324.
Crossref
Crossref
Archita Venugopal Menon & Jonghan Kim. (2022) Iron Promotes Cardiac Doxorubicin Retention and Toxicity Through Downregulation of the Mitochondrial Exporter ABCB8. Frontiers in Pharmacology 13.
Crossref
Crossref
Manuela Curcio, Matteo Brindisi, Giuseppe Cirillo, Luca Frattaruolo, Antonella Leggio, Vittoria Rago, Fiore Pasquale Nicoletta, Anna Rita Cappello & Francesca Iemma. (2022) Smart Lipid–Polysaccharide Nanoparticles for Targeted Delivery of Doxorubicin to Breast Cancer Cells. International Journal of Molecular Sciences 23:4, pages 2386.
Crossref
Crossref
Changping Deng, Fabiao Hu, Zhangting Zhao, Yiwen Zhou, Yuping Liu, Tong Zhang, Shihui Li, Wenyun Zheng, Wenliang Zhang, Tianwen Wang & Xingyuan Ma. (2022) The Establishment of Quantitatively Regulating Expression Cassette with sgRNA Targeting BIRC5 to Elucidate the Synergistic Pathway of Survivin with P-Glycoprotein in Cancer Multi-Drug Resistance. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Md. Rizwanullah, Mohammad Zaki Ahmad, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Shadab Md, Nabil A. Alhakamy, Keerti Jain & Javed Ahmad. (2021) Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges. Pharmaceutics 13:12, pages 2039.
Crossref
Crossref
Nedeljka N. Rosic. (2021) Recent advances in the discovery of novel marine natural products and mycosporine-like amino acid UV-absorbing compounds. Applied Microbiology and Biotechnology 105:19, pages 7053-7067.
Crossref
Crossref
Sahar Ibrahim, Cathy Lan, Catherine Chabot, Georgia Mitsa, Marguerite Buchanan, Adriana Aguilar-Mahecha, Mounib Elchebly, Oliver Poetz, Alan Spatz, Mark Basik, Gerald Batist, René P. Zahedi & Christoph H. Borchers. (2021) Precise Quantitation of PTEN by Immuno-MRM: A Tool To Resolve the Breast Cancer Biomarker Controversy. Analytical Chemistry 93:31, pages 10816-10824.
Crossref
Crossref
Michela Levi, Luisa Vera Muscatello, Barbara Brunetti, Cinzia Benazzi, Federico Parenti, Francesca Gobbo, Giancarlo Avallone, Barbara Bacci, Elisa Zambon, Paola Valenti & Giuseppe Sarli. (2021) High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and Outcome. Animals 11:3, pages 658.
Crossref
Crossref
Ebubekir Dirican, İpek Erbarut Seven, Handan Kaya, M. Ümit Uğurlu, İrem Peker, Bahadır M. Güllüoğlu, Ayşe Özer & Mustafa Akkiprik. (2020)
PIK3CA
and
TP53
MUTATIONS and
SALL4
,
PTEN
and
PIK3R1
GENE EXPRESSION LEVELS in BREAST CANCER
. Turkish Journal of Biochemistry 45:5, pages 515-523.
Crossref
Crossref
Floren G. Low, Kiran Shabir, James E. Brown, Roslyn M. Bill & Alice J. Rothnie. (2020) Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines. International Journal of Molecular Sciences 21:20, pages 7664.
Crossref
Crossref
Elena-Georgiana Dobre, Sorina Dinescu & Marieta Costache. (2020) Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer. Cancers 12:9, pages 2698.
Crossref
Crossref
Qingguo Zhao, Bo Hai, Xiao Zhang, Jing Xu, Brian Koehler & Fei Liu. (2020) Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer. Nanomedicine: Nanotechnology, Biology and Medicine 24, pages 102146.
Crossref
Crossref
Santhosh Kalash Rajendrakumar, Akhil Venu, Vishnu Revuri, Reju George Thomas, Guru Karthikeyan Thirunavukkarasu, Jun Zhang, Veena Vijayan, Seok-Yong Choi, Jae Young Lee, Yong-Kyu Lee, Yong Yeon Jeong & In-Kyu Park. (2019) Hyaluronan-Stabilized Redox-Sensitive Nanoassembly for Chemo-Gene Therapy and Dual T1/T2 MR Imaging in Drug-Resistant Breast Cancer Cells. Molecular Pharmaceutics 16:5, pages 2226-2234.
Crossref
Crossref
Azeez A. Fatai & Junaid Gamieldien. (2018) A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer. BMC Cancer 18:1.
Crossref
Crossref
John Lalith Charles Richard & Pieter Johan Adam Eichhorn. (2018) Deciphering the roles of lncRNAs in breast development and disease. Oncotarget 9:28, pages 20179-20212.
Crossref
Crossref
Lin Zhao, Yan Wang, Longyang Jiang, Miao He, Xuefeng Bai, Lifeng Yu & Minjie Wei. (2016) MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Morteza Ghandadi, Javad Behravan, Khalil Abnous & Fatemeh Mosaffa. (2016) Reactive Oxygen Species Mediate TNF-⍺ Cytotoxic Effects in the Multidrug-Resistant Breast Cancer Cell Line MCF-7/MX. Oncology Research and Treatment 39:1-2, pages 54-59.
Crossref
Crossref
Alessia Carta, Rachel Chetcuti & Duncan Ayers. (2014) An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance. Genetics Research International 2014, pages 1-13.
Crossref
Crossref
Serena Mazzucchelli. (2014) Targeted approaches for HER2 breast cancer therapy: News from nanomedicine?. World Journal of Pharmacology 3:4, pages 72.
Crossref
Crossref